In the January 2016 edition of Financier Worldwide, Dr. Gregory K. Bell discusses how mergers and acquisitions can create shareholder value in the life sciences sector. The roundtable discussion is moderated by James C. Greenwood, President and CEO of the Biotechnology Innovation Organization (BIO). To read the article, click the link below.
Unpacking market power: Why industry prices fell following a merger
The article “Estimating industry conduct using promotion data,” published in the RAND Journal of Economics by CRA’s Christian Michel, with Jose Manuel Paz y...